Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fujifilm Hlds Corp (OP: FUJIY )

12.64 -0.21 (-1.63%)
Streaming Delayed Price Updated: 10:27 AM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fujifilm Hlds Corp

FUJIY Stock Earnings: FUJIFILM Holdings Reported Results for Q4 2023
FUJIFILM Holdings just reported results for the fourth quarter of 2023. 
Via InvestorPlace
FUJIY Stock Earnings: FUJIFILM Holdings Beats EPS, Beats Revenue for Q1 2023
FUJIY stock results show that FUJIFILM Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2023. 
Via InvestorPlace
Biden Asked OPEC+ To Delay Output Decision, Elon Musk Faces Federal Probe Over Twitter Deal, Netflix Ad-Supported Plan: Top Stories Friday, Oct. 14
Reuters Twitter Says Elon Musk Under Federal Probe Over $44B Twitter Deal, In Court Filing 
Via Benzinga
Once Favored By Late Shinzo Abe, Japan Culls Development On Repurposed COVID-19 Treatment
Via Benzinga
Recap: FUJIFILM Q3 Earnings
  FUJIFILM Holdings (OTC:FUJIY) reported its Q3 earnings results on Wednesday, February 9, 2022 at 02:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
Shares of NVAX stock are climbing ahead of the World Vaccine Congress Europe 2022, where Novavax will share new vaccine data. 
Via InvestorPlace
FUJIFILM Holdings: Q4 Earnings Insights
FUJIFILM Holdings (OTC:FUJIY) reported its Q4 earnings results on Wednesday, May 11, 2022 at 02:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Stock Wars: IBM Vs. Xerox
Benzinga’s latest Stock Wars matches up two leaders in a major industry sector, with the goal of letting readers decide which company is ... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.